Dr. Alok Narang

Dr. Alok Narang is a Senior Surgical Oncologist with over 27 years of specialized experience in comprehensive cancer care. He holds an MBBS and MS in General Surgery, and brings deep clinical expertise in evidence-based surgical oncology. As a trusted oncology surgeon, Dr. Narang has built a reputation for combining advanced surgical techniques with patient-centered care, focusing on optimal tumor removal while preserving organ function wherever possible.

Dr. Narang's clinical depth spans multiple oncology domains. He is highly proficient in breast oncology, including sentinel lymph node biopsy, breast-conserving surgery, and oncoplastic breast surgery. His surgical portfolio also encompasses head and neck tumors, gastric and colorectal cancers, ovarian and cervical cancers, bone and soft tissue sarcomas, and peritoneal surface malignancies. He is particularly experienced in cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC), a complex multimodal approach for advanced peritoneal cancers.

International patients from across the Gulf, Africa, and South Asia regularly seek Dr. Narang's care, drawn by his reputation for meticulous surgical planning and compassionate follow-up. He is actively engaged in tobacco cessation counseling, integrating cancer prevention into his patient management philosophy. His fluency in English and Hindi ensures clear communication with diverse international cohorts.

Dr. Narang practices at Indraprastha Apollo Hospital in Delhi, one of India's premier tertiary care centers. Apollo's NABH-accredited infrastructure, 24/7 ICU support, and dedicated oncology unit provide a robust platform for complex surgical cases and comprehensive cancer management. The hospital's international patient services facilitate seamless coordination for overseas visitors, from pre-operative imaging review to post-operative follow-up via telemedicine.

For international patients considering surgical oncology in India, Dr. Narang represents a blend of technical precision, evidence-based decision-making, and genuine investment in long-term outcomes. His membership in the Indian Association of Surgical Oncology and Indian Society of Oncology underscores his commitment to staying current with global cancer care standards.